The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
A Comprehensive Review of Opioid-Induced Hyperalgesia
Open accessAbstract
Opioid-induced hyperalgesia (OIH) is defined as a state of nociceptive sensitization caused by exposure to opioids. The condition is characterized by a paradoxical response whereby a patient receiving opioids for the treatment of pain could actually become more sensitive to certain painful stimuli. The type of pain experienced might be the same as the underlying pain or might be different from the original underlying pain. OIH appears to be a distinct, definable, and characteristic phenomenon that could explain loss of opioid efficacy in some patients. Findings of the clinical prevalence of OIH are not available. However, several observational, cross-sectional, and prospective controlled trials have examined the expression and potential clinical significance of OIH in humans. Most studies have been conducted using several distinct cohorts and methodologies utilizing former opioid addicts on methadone maintenance therapy, perioperative exposure to opioids in patients undergoing surgery, and healthy human volunteers after acute opioid exposure using human experimental pain testing. The precise molecular mechanism of OIH, while not yet understood, varies substantially in the basic science literature, as well as clinical medicine. It is generally thought to result from neuroplastic changes in the peripheral and central nervous system (CNS) that lead to sensitization of pronociceptive pathways. While there are many proposed mechanisms for OIH, 5 mechanisms involving the central glutaminergic system, spinal dynorphins, descending facilitation, genetic mechanisms, and decreased reuptake and enhanced nociceptive response have been described as the important mechanisms. Of these, the central glutaminergic system is considered the most common possibility. Another is the hypothesis that N-methyl-D-aspartate (NMDA) receptors in OIH include activation, inhibition of the glutamate transporter system, facilitation of calcium regulated intracellular protein kinase C, and cross talk of neural mechanisms of pain and tolerance. Clinicians should suspect OIH when opioid treatment’s effect seems to wane in the absence of disease progression, particularly if found in the context of unexplained pain reports or diffuse allodynia unassociated with the original pain, and increased levels of pain with increasing dosages. The treatment involves reducing the opioid dosage, tapering them off, or supplementation with NMDA receptor modulators. This comprehensive review addresses terminology and definition, prevalence, the evidence for mechanism and physiology with analysis of various factors leading to OIH, and effective strategies for preventing, reversing, or managing OIH. Key words: Opioid-induced hyperalgesia, opioid tolerance, opioid sensitivity, adverse events, chronic opioid therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–211 of 211
Pain Perception of Intravenous Heroin Users on Maintenance Therapy with Levomethadone
Schall, U., KATTA, T., PRIES, E., Klöppel, A., & Gastpar, M. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979567 · Cited by 31
The Effect of Spinal Ibuprofen on Opioid Withdrawal in the Rat
Dunbar, S. A., Karamov, I. G., & Buerkle, H. (2000) · Anesthesia & Analgesia · doi:10.1097/00000539-200008000-00035 · Cited by 31
Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors
Sakurada, T., Watanabe, C., Okuda, K., Sugiyama, A., Moriyama, T., Sakurada, C., Tan–No, K., & Sakurada, S. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00332-1 · Cited by 30
Mapping of a quantitative trait locus for morphine withdrawal severity
Kest, B., Palmese, C. A., Juni, A., Chesler, E. J., & Mogil, J. S. (2004) · Mammalian Genome · doi:10.1007/s00335-004-2367-3 · Cited by 28
Dexmedetomidine Fails to Cause Hyperalgesia After Cessation of Chronic Administration
Davies, M. F., Haimor, F., Lighthall, G. K., & Clark, J. D. (2003) · Anesthesia & Analgesia · doi:10.1097/00000539-200301000-00041 · Cited by 28
Rossbach, M. J. (1880) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf01637005 · Cited by 23
Moises, H. C., & Smith, C. B. (1987) · Brain Research · doi:10.1016/0006-8993(87)90658-5 · Cited by 22
Successful treatment of hydromorphone-induced neurotoxicity and hyperalgesia.
Chung, K. S., Carson, S., Glassman, D. M., & Vadivelu, N. (2004) · PubMed · Cited by 16
CBT for low-back pain in primary care
Manchikanti, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60277-2 · Cited by 9
Moises, H. C., & Smith, C. B. (1989) · Brain Research · doi:10.1016/0006-8993(89)90667-7 · Cited by 7
Hill, J. C., Foster, N. E., & Hay, E. M. (2010) · BMJ Evidence-Based Medicine · doi:10.1136/ebm1085 · Cited by 7
Cited by
Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies
Volkow, N. D., & McLellan, A. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1507771 · Cited by 1,305
Opioid Epidemic in the United States
Manchikanti, L. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es9 · Cited by 1,180
Paice, J. A., Portenoy, R., Lacchetti, C., Campbell, T., Cheville, A., Citron, M., Constine, L. S., Cooper, A., Glare, P., Keefe, F., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.5206 · Cited by 599
Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl− homeostasis
Ferrini, F., Trang, T., Mattioli, T.-A. M., Laffray, S., Del'Guidice, T., Lorenzo, L.-E., Castonguay, A., Doyon, N., Zhang, W., Godin, A. G., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3295 · Cited by 437
Essential Elements of Multimodal Analgesia in Enhanced Recovery After Surgery (ERAS) Guidelines
Beverly, A., Kaye, A. D., Ljungqvist, O., & Urman, R. D. (2017) · Anesthesiology Clinics · doi:10.1016/j.anclin.2017.01.018 · Cited by 432
Metadata
- Authors
- Lee, M. O.
- Venue
- Pain Physician
- Published
- 2011-03-14
- Volume
- 3;14
- Issue
- 2;3
- Pages
- 145-161
- ISSN
- 1533-3159 (ISSN-L)
- 2150-1149
- OpenAlex
- W2144694293
- Cited by
- 1,118
- References
- 211
- FWCI
- 39.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.